Trial intelligence / Profile preview

FERRIC-HF: IV Iron Sucrose in Chronic Heart Failure

NCT00125996Phase 2Unknown

Sponsor
National Heart and Lung Institute
Start
Jul 2004
Modality
Small Molecules
Countries
2
01

Overview

Phase 2, randomised, single-blind trial in chronic heart failure (CHF) and iron deficiency anemia (IDA) comparing IV iron sucrose with Placebo (2 arms). Primary endpoint: Peak Oxygen Consumption at 18 weeks. Status: unknown.

02

Drugs

iron sucrose
03

Conditions

chronic heart failure (CHF)iron deficiency anemia (IDA)

Beyond the preview

Go deeper on NCT00125996.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00125996.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call